1. Home
  2. ARMP vs IMMR Comparison

ARMP vs IMMR Comparison

Compare ARMP & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.41

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$7.44

Market Cap

215.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
IMMR
Founded
N/A
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
215.8M
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
ARMP
IMMR
Price
$5.41
$7.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$15.00
$13.50
AVG Volume (30 Days)
93.2K
336.6K
Earning Date
05-07-2026
04-13-2026
Dividend Yield
N/A
5.11%
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$35,013,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$54.50
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$5.25
52 Week High
$14.98
$8.05

Technical Indicators

Market Signals
Indicator
ARMP
IMMR
Relative Strength Index (RSI) 55.53 47.84
Support Level $5.12 $7.34
Resistance Level $5.63 $7.93
Average True Range (ATR) 0.47 0.20
MACD 0.08 -0.04
Stochastic Oscillator 84.37 13.28

Price Performance

Historical Comparison
ARMP
IMMR

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

Share on Social Networks: